Showing 1,277 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Scientists reveal new phase of HIV infection

Editor's pick
Science Daily
19 December 2015
Pharmaceutical industry

Bristol-Myers Squibb to Sell its HIV R&D Portfolio to ViiV Healthcare

Editor's pick
Bristol-Myers Squibb press release
18 December 2015
New & experimental HIV treatments

Tenofovir alafenamide fumarate at what price? No more than $1000 a year above existing tenofovir formulation, says model

News
18 December 2015
Treatment simplification strategies

Two-drug ART with dolutegravir-lamivudine would be cost-effective and achieve substantial cash savings

News
17 December 2015
The search for a cure

Sangamo BioSciences Presents Phase 2 Clinical Data From Two SB-728-T HIV Studies

Editor's pick
Sangamo Biosciences press release
14 December 2015
New & experimental HIV treatments

The Medicines Patent Pool Signs a Collaborative Agreement with the University of Liverpool to Develop HIV Nanomedicines

Editor's pick
Medicines Patent Pool
3 December 2015
Access to healthcare

Three new agreements announced with the potential to expand access to innovative HIV treatment in low- and middle-income countries

Editor's pick
UNITAID
1 December 2015
New & experimental HIV treatments

Cipla ready to launch low dose HIV drug efavirenz

Editor's pick
Economic Times
1 December 2015
New & experimental HIV treatments

Two-drug maintenance therapy keeps viral load suppressed and may even have advantages over traditional ART

News
30 November 2015
New & experimental HIV treatments

European Commission Grants Marketing Authorization for Gilead’s Single Tablet Regimen Genvoya®

Editor's pick
Gilead press release
23 November 2015
New & experimental HIV treatments

Genvoya added to US recommended first-line options for HIV treatment

Editor's pick
AIDSinfo
23 November 2015
New & experimental HIV treatments

FDA approves new treatment for HIV

Editor's pick
FDA press release
6 November 2015
Injectable & long-acting HIV treatment

Long-acting injectable HIV treatment shows promise in early study results

Editor's pick
Science Speaks
4 November 2015
New & experimental HIV treatments

ViiV Healthcare announces positive headline results from a study of two drug injectable regimen for HIV maintenance therapy

Editor's pick
ViiV Healthcare
3 November 2015
New & experimental HIV treatments

HIV maturation inhibitor BMS-955176 shows good safety and efficacy in phase 2a trial

News
28 October 2015
New & experimental HIV treatments

Tenofovir alafenamide single-tablet regimen shows good efficacy with improved kidney and bone safety

News
25 October 2015
Treatment simplification strategies

Can dolutegravir dual therapy or monotherapy produce and maintain HIV suppression?

News
23 October 2015
New & experimental HIV treatments

Studies continue to support tenofovir alafenamide combination pill as it nears US approval

News
19 October 2015
New & experimental HIV treatments

HIV attachment inhibitor BMS-663068 matches atazanavir in phase 2b study

News
14 October 2015
Side effects

TAF and TDF Compared for Kidney, Bone Toxicity in Black HIV+ Patients

Editor's pick
Monthly Prescribing Reference
12 October 2015
HIV treatment

New antiretrovirals and HIV treatment strategies highlighted at ICAAC

News
7 October 2015
Pharmaceutical industry

European CHMP adopts positive opinion for Gilead’s single tablet regimen Genvoya® (elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide) for the treatment of HIV

Editor's pick
EATG
1 October 2015
Changing treatment

New Phase IIIb/IV Data Show Switching to Once-Daily Triumeq® Maintains HIV Viral Suppression

Editor's pick
Viiv Healthcare press release
23 September 2015
New & experimental HIV treatments

HIV Patients Successfully Reach One Year of Virologic Suppression in PRO 140 Monotherapy Study

Editor's pick
Cytodyn press release
22 September 2015